Annual report pursuant to Section 13 and 15(d)

Summary of Significant Accounting Policies (Details 2)

v3.20.1
Summary of Significant Accounting Policies (Details 2) - USD ($)
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Medical related consulting services - related parties $ 355,544 $ 269,287
Development services and sales of developed products 35,084 171,516
Total revenues 1,546,305 1,562,286
Medical related consulting services [Member]    
Medical related consulting services - related parties 355,544 269,287
Development services and sales of developed products
Total revenues 355,544 269,287
Development services and sales of developed products[Member]    
Medical related consulting services - related parties
Development services and sales of developed products 35,084 171,516
Total revenues $ 35,084 $ 171,516